Solicitation Amendment 2
Updated
A PDF document (388 KB) attached to 2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases, from the National Institutes of Health. Due Dec 8, 2026, 3:00 PM (UTC-5).
File name: Solicitation Amendment 2 - HHS-NIH-NIAID-BAA2026-1.pdf
The full file is for paid members, or buy this bid alone.
Preview
NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES (NIAID)
2027 DMID Omnibus Broad Agency Announcement (BAA):
No. HHS-NIH-NIAID-BAA2026-1
Solicitation Amendment (Two) 2:
Requiring Office:
National Institute of Allergy and Infectious Diseases
5601 Fishers Lane, MSC 9821, Bethesda, MD 20892-9821
Issuing Office:
National Institutes of Health
NIH OD/OA/R&D Division A-3, OALM
6701 Rockledge Drive, RKL2, 4th Floor
Bethesda, MD 20817
Contracting Officer:
Alexandra J. Buck, JD
Email: [email protected]
Solicitation Number:
HHS-NIH-NIAID-BAA2026-1
Date of Solicitation Issuance:
October 9, 2026
Date of Amendment One Issuance
November 16, 2026
Number of Pages:
17 pages
Proposal Due Dates:
The hour and date specified for receipt of offers for each Research Area remains unchanged:
RESEARCH
AREA
TITLE
SOLICITATION
PAGE NO.
PROPOSALS
DUE*
Vaccine Candidates
December 8,
2026
Therapeutic Candidates
December 8,
2026
In Vitro Diagnostics
December 8,
2026
HHS-NIH-NIAID-BAA2026-1
Amendment Two (2)
* Proposals must be received before 3:00 PM Eastern Standard Time on the date specified herein. Please see the Proposal Submission Instructions (Section 4.3.2.1) for more information. For planning purposes, the Government requests potential Offerors to submit a Notice of Intent. Please see Notice of Intent (Section 4.3.2.1.4) for more information. Offers will be valid for 240 days unless a different period is specified by the Offeror on the Attachment entitled, "Proposal Summary and Data Record, NIH 2043”. Offerors MUST acknowledge receipt of the amendment by Amendment number (s) and date of the amendment. Failure to receive your acknowledgment of this amendment may result in the rejection of your proposal.
Except as provided herein, all terms and conditions of the solicitation remain unchanged and in full force and effect.
PURPOSE OF SOLICITATION AMENDMENT #2
The purpose of Amendment #2 is to:
1) Provide the NIAID’s response to questions received regarding the solicitation, and 2) Provide an update for anticipated awards ~ September 2027. Research Areas 001, 002 and 003: For Fiscal Year (FY) 27, NIAID estimates up to $16 million for the award of up to 4 cost reimbursement completion type contracts. The estimated FY 27 funding is for the non-severable Base Requirement (direct and indirect costs combined) only. If options are proposed by an Offeror, they will be evaluated in accordance with Section 6 of the BAA. The number of awarded contracts will depend on the number of technically meritorious
The beginning of the document. Download the full file to read on.